Renvela
These highlights do not include all the information needed to use RENVELA safely and effectively. See full prescribing information for RENVELA. RENVELA (sevelamer carbonate) tablets, for oral use RENVELA (sevelamer carbonate) powder, for oral suspension Initial U.S. Approval: 2000
e6328460-a57b-450b-a48c-6dcd4b476360
HUMAN PRESCRIPTION DRUG LABEL
Sep 25, 2023
Genzyme Corporation
DUNS: 025322157
Products 4
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
SEVELAMER CARBONATE
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (5)
SEVELAMER CARBONATE
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (5)
SEVELAMER CARBONATE
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (7)
SEVELAMER CARBONATE
Product Details
FDA regulatory identification and product classification information